Jan. 16, 2014
Star Scientific Inc. says it's working with the Food and Drug Administration to avoid having to pull two dietary supplement products from the market.
Dr. Michael Mullan, the company's new CEO, held a short conference call Wednesday to discuss recent developments with investors.
Media outlets report that Mullan acknowledged that Star Scientific could be required to discontinue marketing Anatabloc and CigRx as dietary supplements.
In December, the FDA sent a warning letter to the company saying that the products contain a new dietary ingredient that requires federal approval before it can be marketed. Star Scientific did not seek such approval.
The FDA also said Star Scientific's website improperly promotes Anatabloc as a drug by suggesting it can be used to treat various diseases.
The comments sections of Newsplex.com are designed for thoughtful, intelligent conversation and debate. We want to hear from our viewers, but we only ask that you use your best judgment. E-mail is required, but will not be displayed with comment.
As a host Newsplex.com welcomes a wide spectrum of opinions. However this is a site that we host. We have a responsibility to all our readers to try to keep our comment section fair and decent. For that reason The Newsplex reserves the right to not post or to remove any comment.
If you have any ideas to improve the conversation or this section let us know. Send an e-mail to firstname.lastname@example.org.
powered by Disqus